File Download
 
Links for fulltext
(May Require Subscription)
 
Supplementary

Article: In patients with a high 5 year risk of death, does simvastatin reduce mortality and vascular events?
  • Basic View
  • Metadata View
  • XML View
TitleIn patients with a high 5 year risk of death, does simvastatin reduce mortality and vascular events?
 
AuthorsKumana, CR
Cheung, BM
Lauder, IJ
 
KeywordsArtery Occlusion
Cancer Incidence
Cardiovascular Disease
Clinical Trial
Death
Diabetes Mellitus
Diet Restriction
Diet Supplementation
Dose Response
Drug Safety
Drug Use
Factorial Analysis
Follow Up
Heart Protection
High Risk Patient
Human
Hypertension
Ischemic Heart Disease
Malignant Neoplastic Disease
Mortality
Patient Compliance
Patient Selection
Prescription
Quality Of Life
Risk Assessment
Risk Reduction
Short Survey
Stroke
Treatment Outcome
United Kingdom
Vascular Disease
 
Issue Date2003
 
PublisherB M J Publishing Group. The Journal's web site is located at http://www.evidence-basedmedicine.com
 
CitationEvidence-Based Medicine, 2003, v. 8 n. 1, p. 10 [How to Cite?]
DOI: http://dx.doi.org/10.1136/ebm.8.1.10
 
ISSN1356-5524
 
DOIhttp://dx.doi.org/10.1136/ebm.8.1.10
 
ReferencesReferences in Scopus
 
DC FieldValue
dc.contributor.authorKumana, CR
 
dc.contributor.authorCheung, BM
 
dc.contributor.authorLauder, IJ
 
dc.date.accessioned2010-09-17T10:22:22Z
 
dc.date.available2010-09-17T10:22:22Z
 
dc.date.issued2003
 
dc.description.naturelink_to_subscribed_fulltext
 
dc.identifier.citationEvidence-Based Medicine, 2003, v. 8 n. 1, p. 10 [How to Cite?]
DOI: http://dx.doi.org/10.1136/ebm.8.1.10
 
dc.identifier.doihttp://dx.doi.org/10.1136/ebm.8.1.10
 
dc.identifier.issn1356-5524
 
dc.identifier.issue1
 
dc.identifier.scopuseid_2-s2.0-80051953944
 
dc.identifier.spage10
 
dc.identifier.urihttp://hdl.handle.net/10722/91623
 
dc.identifier.volume8
 
dc.languageeng
 
dc.publisherB M J Publishing Group. The Journal's web site is located at http://www.evidence-basedmedicine.com
 
dc.relation.ispartofEvidence-Based Medicine
 
dc.relation.referencesReferences in Scopus
 
dc.subjectArtery Occlusion
 
dc.subjectCancer Incidence
 
dc.subjectCardiovascular Disease
 
dc.subjectClinical Trial
 
dc.subjectDeath
 
dc.subjectDiabetes Mellitus
 
dc.subjectDiet Restriction
 
dc.subjectDiet Supplementation
 
dc.subjectDose Response
 
dc.subjectDrug Safety
 
dc.subjectDrug Use
 
dc.subjectFactorial Analysis
 
dc.subjectFollow Up
 
dc.subjectHeart Protection
 
dc.subjectHigh Risk Patient
 
dc.subjectHuman
 
dc.subjectHypertension
 
dc.subjectIschemic Heart Disease
 
dc.subjectMalignant Neoplastic Disease
 
dc.subjectMortality
 
dc.subjectPatient Compliance
 
dc.subjectPatient Selection
 
dc.subjectPrescription
 
dc.subjectQuality Of Life
 
dc.subjectRisk Assessment
 
dc.subjectRisk Reduction
 
dc.subjectShort Survey
 
dc.subjectStroke
 
dc.subjectTreatment Outcome
 
dc.subjectUnited Kingdom
 
dc.subjectVascular Disease
 
dc.titleIn patients with a high 5 year risk of death, does simvastatin reduce mortality and vascular events?
 
dc.typeArticle
 
<?xml encoding="utf-8" version="1.0"?>
<item><contributor.author>Kumana, CR</contributor.author>
<contributor.author>Cheung, BM</contributor.author>
<contributor.author>Lauder, IJ</contributor.author>
<date.accessioned>2010-09-17T10:22:22Z</date.accessioned>
<date.available>2010-09-17T10:22:22Z</date.available>
<date.issued>2003</date.issued>
<identifier.citation>Evidence-Based Medicine, 2003, v. 8 n. 1, p. 10</identifier.citation>
<identifier.issn>1356-5524</identifier.issn>
<identifier.uri>http://hdl.handle.net/10722/91623</identifier.uri>
<language>eng</language>
<publisher>B M J Publishing Group. The Journal&apos;s web site is located at http://www.evidence-basedmedicine.com</publisher>
<relation.ispartof>Evidence-Based Medicine</relation.ispartof>
<subject>Artery Occlusion</subject>
<subject>Cancer Incidence</subject>
<subject>Cardiovascular Disease</subject>
<subject>Clinical Trial</subject>
<subject>Death</subject>
<subject>Diabetes Mellitus</subject>
<subject>Diet Restriction</subject>
<subject>Diet Supplementation</subject>
<subject>Dose Response</subject>
<subject>Drug Safety</subject>
<subject>Drug Use</subject>
<subject>Factorial Analysis</subject>
<subject>Follow Up</subject>
<subject>Heart Protection</subject>
<subject>High Risk Patient</subject>
<subject>Human</subject>
<subject>Hypertension</subject>
<subject>Ischemic Heart Disease</subject>
<subject>Malignant Neoplastic Disease</subject>
<subject>Mortality</subject>
<subject>Patient Compliance</subject>
<subject>Patient Selection</subject>
<subject>Prescription</subject>
<subject>Quality Of Life</subject>
<subject>Risk Assessment</subject>
<subject>Risk Reduction</subject>
<subject>Short Survey</subject>
<subject>Stroke</subject>
<subject>Treatment Outcome</subject>
<subject>United Kingdom</subject>
<subject>Vascular Disease</subject>
<title>In patients with a high 5 year risk of death, does simvastatin reduce mortality and vascular events?</title>
<type>Article</type>
<description.nature>link_to_subscribed_fulltext</description.nature>
<identifier.doi>10.1136/ebm.8.1.10</identifier.doi>
<identifier.scopus>eid_2-s2.0-80051953944</identifier.scopus>
<relation.references>http://www.scopus.com/mlt/select.url?eid=2-s2.0-3042687499&amp;selection=ref&amp;src=s&amp;origin=recordpage</relation.references>
<identifier.volume>8</identifier.volume>
<identifier.issue>1</identifier.issue>
<identifier.spage>10</identifier.spage>
</item>
Author Affiliations
  1. Clinical Trial Service Unit